Mar 22, 2019

The European Falsified Medicines Directive took effect on 9 February 2019 – Yusen Logistics introduces serialization solutions

In order to prevent falsified or imitation medicines to enter the market, The European Falsified Medicines Directive requires all pharmaceutical products to be tamper evident and individually identifiable using a unique 2D Barcode Data Matrix as from 9 February 2019.


During the end-to-end supply chain, the pharmaceutical products must be registered by the manufacturer at the European Medicines Verification Organization (EMVO). The EMVO makes these registrations available per country via the National Medicines Verification Systems (NMVS).


In order to support their customers in the pharmaceutical industry, healthcare logistics specialist Yusen Logistics has introduced a specialized Serialization service. With this service, Yusen Logistics will support pharmaceutical manufacturers with the necessary verification and decommissioning activities within the appropriate NMVS.


Yusen Logistics’ Serialization software is available on all state-of-the-art handheld terminals and is available with immediate effect. Alongside this, Yusen Logistics is able to provide all pharma manufacturers with a dedicated periodical report of all verified and decommissioned products. Serialization services are available for all customers from the pharmaceutical industry and will be provided at every major Yusen Logistics Pharma and Healthcare logistics center within the EU.